We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.6B
AUM Growth
+$506M
Cap. Flow
-$208M
Cap. Flow %
-2.17%
Top 10 Hldgs %
16.85%
Holding
2,391
New
63
Increased
104
Reduced
1,016
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Financials 14.83%
3 Healthcare 13.13%
4 Industrials 10.01%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPLX icon
101
MPLX
MPLX
$60.1B
$17.8M 0.19%
700,797
-84,000
-11% -$2.14M
IWM icon
102
iShares Russell 2000 ETF
IWM
$81.8B
$17.8M 0.19%
107,500
+14,100
+15% +$2.23M
SO icon
103
Southern Company
SO
$106B
$17.7M 0.18%
278,595
-5,850
-2% -$363K
SPGI icon
104
S&P Global
SPGI
$120B
$17.7M 0.18%
64,925
-2,102
-3% -$546K
DUK icon
105
Duke Energy
DUK
$96.1B
$17.7M 0.18%
193,667
-4,612
-2% -$423K
FISV
106
Fiserv Inc
FISV
$28B
$17.5M 0.18%
151,715
-3,625
-2% -$400K
TGT icon
107
Target
TGT
$69.2B
$17.3M 0.18%
134,614
-4,428
-3% -$520K
ZTS icon
108
Zoetis
ZTS
$31.1B
$16.7M 0.17%
126,528
-3,433
-3% -$427K
BSX icon
109
Boston Scientific
BSX
$74.2B
$16.7M 0.17%
370,268
-8,811
-2% -$369K
MS icon
110
Morgan Stanley
MS
$338B
$16.7M 0.17%
326,784
-15,047
-4% -$712K
AGN
111
DELISTED
Allergan plc
AGN
$16.7M 0.17%
87,207
-2,063
-2% -$372K
RTN
112
DELISTED
Raytheon Company
RTN
$16.3M 0.17%
73,978
-1,811
-2% -$383K
WMB icon
113
Williams Companies
WMB
$88.4B
$16.1M 0.17%
676,697
-7,855
-1% -$180K
MU icon
114
Micron Technology
MU
$981B
$15.8M 0.16%
294,087
-6,298
-2% -$301K
BLK icon
115
Blackrock
BLK
$178B
$15.7M 0.16%
31,329
-641
-2% -$304K
CCI icon
116
Crown Castle
CCI
$31.3B
$15.7M 0.16%
110,448
-2,694
-2% -$368K
CL icon
117
Colgate-Palmolive
CL
$73.6B
$15.7M 0.16%
227,673
-5,821
-2% -$397K
AMAT icon
118
Applied Materials
AMAT
$417B
$15M 0.16%
245,394
-5,993
-2% -$337K
PLD icon
119
Prologis
PLD
$133B
$15M 0.16%
167,823
-3,930
-2% -$348K
VRTX icon
120
Vertex Pharmaceuticals
VRTX
$134B
$15M 0.16%
68,312
-1,637
-2% -$331K
CSX icon
121
CSX Corp
CSX
$92.5B
$14.9M 0.16%
619,734
-31,902
-5% -$755K
MRSH
122
Marsh
MRSH
$91.3B
$14.9M 0.16%
134,065
-3,721
-3% -$389K
SLB icon
123
SLB Ltd
SLB
$79.7B
$14.8M 0.15%
367,762
-8,604
-2% -$307K
KMI icon
124
Kinder Morgan
KMI
$70.1B
$14.6M 0.15%
692,005
-185,365
-21% -$3.75M
GPN icon
125
Global Payments
GPN
$22.7B
$14.6M 0.15%
79,840
-1,812
-2% -$311K

Similar funds

MetLife Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, MetLife Investment Management held 2,391 positions worth $9.6B, up 5.6% from $9.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management's Q4 2019 filing shows 63 new, 104 increased, 1,016 reduced and 90 closed positions. Its largest new stake was ServiceNow: 250,510 shares worth $14.1M. The largest sale was Celgene Corp, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2019 buy was ServiceNow: 250,510 shares worth $14.1M.
  • MetLife Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $10.2M increase.
  • MetLife Investment Management's biggest Q4 2019 reduction was Apple, cutting an estimated $12M.
  • MetLife Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $19.2M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $9.6B portfolio in Q4 2019.
  • MetLife Investment Management opened 63 new positions and closed 90 in Q4 2019.
  • MetLife Investment Management's portfolio value rose 5.6% quarter-over-quarter to $9.6B.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.